logo

Mekong countries call for accelerated action to eliminate malaria before 2030

Drug resistance is still the main concern for health authorities in Cambodia, China, Laos, Myanmar, Thailand and Vietnam. 
Today, representatives from these countries called for accelerated action to eliminate malaria in the Greater Mekong Subregion (GMS) by the year 2030.
The call comes amid concern over resistance of malaria parasites to antimalarial drugs, including artemisinin—the core compound of the best available anti-malarial medicines. To date, resistance has been detected in five of the six GMS countries. The best way to address the threat posed by drug-resistance is to eliminate malaria altogether from the countries of the Mekong.
Representatives from the six countries’ stressed that eliminating malaria in the sub-region requires urgent and coordinated action, with support from implementing agencies, funders and other partners.
Health authorities met at a high-level meeting in Myanmar, organised by the Ministry of Health of Myanmar in collaboration with the World Health Organisation (WHO) and the Asia Pacific Leaders Malaria Alliance (APLMA),
The meeting pledged to:

The map shows six countries concerned over the resistance of malaria parasites to antimalarial drugs.

• ensure that activities to eliminate malaria in the sub-region are fully funded, including using more domestic funds;
• improve cross-border collaboration and establish an independent oversight body, for which WHO will act as the secretariat;
• strengthen systems for the identification and timely reporting of malaria infections, including drug-resistant forms;
• provide the best possible prevention, diagnosis and care for  all people at risk of malaria, including free services for ethnic minorities and mobile and migrant populations, as part of universal health coverage;
• ensure available antimalarial medicines are safe and effective for use;
• bring all concerned sectors together to translate policies into time-bound and results-oriented actions; and
• engage communities in malaria elimination using innovative communication tools.
Countries requested support from WHO to achieve their malaria elimination goals.
“Malaria is a disease that we can—and must—eliminate from the Greater Mekong Sub-region. The drive to achieve this goal by 2030 demonstrates the joint commitment of health leaders from across the Sub-region to secure the health and well-being of vulnerable populations and ensure no one is left behind,” said WHO Regional Director for South-East Asia, Dr Poonam Khetrapal Singh, 
“The Anopheles mosquito does not need a passport or a visa to cross borders. You must work more closely together as one region, with one strategy to drive elimination.  Accelerating malaria elimination in the Greater Mekong will not only improve lives today.  It will also free future generations from the plague of malaria, and set an example for the rest of the world,” said Dr Shin Young-soo, WHO Regional Director for the Western Pacific.
WHO helps governments achieve malaria elimination by:
•  setting and disseminating guidance and policies on malaria control and elimination;
•  supporting countries as they adapt, adopt and implement WHO global norms and standards for malaria control and elimination;
•  assisting countries in the implementation of national malaria strategic plans;
•  helping countries develop robust malaria surveillance systems;
•  responding to requests from countries to address threats, operational emergencies and bottleneck issues.
Recent efforts to fight malaria in the GMS have yielded impressive results. According to the latest WHO estimates, malaria cases in the six countries fell by an estimated 74 percent between 2012 and 2016. Deaths due to malaria fell by 91 percent over the same period.
This progress was made possible through greater access to effective malaria control tools, particularly artemisinin-based combination therapies for malaria treatment, rapid diagnostic tests, and insecticide-treated nets. Since 2012, targeted provision of these tools to vulnerable populations has increased substantially across the sub-region, leading to acceleration in the pace of progress.Resistance to anti-malarial drugs, unless addressed with urgency, couldundermine these gains.
Malaria is a life-threatening disease caused by Plasmodium parasites that are transmitted to people through the bites of infected female Anopheles mosquitoes. WHO-recommended malaria control tools include: long-lasting insecticidal bed-nets, spraying inside walls of dwellings with insecticides, preventive treatment for infants and during pregnancy, prompt diagnostic testing, and treatment of confirmed cases with effective anti-malarial medicines.

Source: http://www.vientianetimes.org.la/sub-new/Health/Health_Mekong287.html